Editorial comment on Chinese expert consensus on prostate-pelvic syndrome

In a consensus article published in Current Urology in 2026, it presented the experts’ consensus on prostate-pelvic syndrome (PPS), with an attempt to incorporate chronic nonbacterial prostatitis, prostate pain, and type III prostatitis. The goal of this study was to simplify our understanding of chronic nonbacterial prostatitis/pelvic pain syndrome and promote accurate diagnosis and effective management by reducing overdiagnosis and unnecessary interventions.[1] The authors are warmly congratulated for this thoughtful and clinically relevant expert consensus. By integrating the aforementioned pathologies into a unified conceptual framework, they effectively provide a clear and practical approach to a clinical problem that has long been characterized by diagnostic ambiguity and therapeutic frustration for both clinicians and patients. The proposed algorithm is particularly welcome because it reflects current evidence demonstrating that chronic bacterial prostatitis represents a small minority of prostatitis cases and that the traditional leukocyte-based subclassification of chronic prostatitis/chronic PPS (type IIIA vs. IIIB) lacks validated clinical utility and is no longer recommended.[2,3] By moving away from rigid and often misleading diagnostic distinctions, this consensus promotes a more rational patient-centered approach. An additional strength of this study lies in its acknowledgment of the heterogeneous and overlapping nature of PPS.[3–7] In daily practice, many patients present with symptoms influenced by associated conditions, such as interstitial cystitis/bladder pain syndrome, seminal vesicle pathology, symptomatic prostatic calcifications, or neuropathic pelvic pain syndromes. Recognition of these overlapping entities is essential as they may significantly influence symptom presentation and the treatment response.[8] Our phenotype-oriented strategy provides a flexible framework that accommodates this complexity while remaining practical and accessible. Overall, this consensus offers an important and timely contribution to this field. The emphasis on simplification, without oversimplification or individualized multimodal management, is likely to resonate strongly with practicing urologists. Most importantly, it has the potential to improve patients’ understanding, satisfaction, and quality of life—outcomes that ultimately define the success of any clinical framework.

Authors

Institutions

Publication Details

Journal
Current Urology
Published
2026-03-03
DOI
https://doi.org/10.1097/cu9.0000000000000341
Primary Topic
Urinary Bladder and Prostate Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Editorial comment on Chinese expert consensus on prostate-pelvic syndrome

Sergey Kravchick
Current Urology
Urinary Bladder and Prostate Research
article

Editorial comment on Chinese expert consensus on prostate-pelvic syndrome

Sergey Kravchick
article en

Abstract

In a consensus article published in Current Urology in 2026, it presented the experts’ consensus on prostate-pelvic syndrome (PPS), with an attempt to incorporate chronic nonbacterial prostatitis, prostate pain, and type III prostatitis. The goal of this study was to simplify our understanding of chronic nonbacterial prostatitis/pelvic pain syndrome and promote accurate diagnosis and effective management by reducing overdiagnosis and unnecessary interventions.[1] The authors are warmly congratulated for this thoughtful and clinically relevant expert consensus. By integrating the aforementioned pathologies into a unified conceptual framework, they effectively provide a clear and practical approach to a clinical problem that has long been characterized by diagnostic ambiguity and therapeutic frustration for both clinicians and patients. The proposed algorithm is particularly welcome because it reflects current evidence demonstrating that chronic bacterial prostatitis represents a small minority of prostatitis cases and that the traditional leukocyte-based subclassification of chronic prostatitis/chronic PPS (type IIIA vs. IIIB) lacks validated clinical utility and is no longer recommended.[2,3] By moving away from rigid and often misleading diagnostic distinctions, this consensus promotes a more rational patient-centered approach. An additional strength of this study lies in its acknowledgment of the heterogeneous and overlapping nature of PPS.[3–7] In daily practice, many patients present with symptoms influenced by associated conditions, such as interstitial cystitis/bladder pain syndrome, seminal vesicle pathology, symptomatic prostatic calcifications, or neuropathic pelvic pain syndromes. Recognition of these overlapping entities is essential as they may significantly influence symptom presentation and the treatment response.[8] Our phenotype-oriented strategy provides a flexible framework that accommodates this complexity while remaining practical and accessible. Overall, this consensus offers an important and timely contribution to this field. The emphasis on simplification, without oversimplification or individualized multimodal management, is likely to resonate strongly with practicing urologists. Most importantly, it has the potential to improve patients’ understanding, satisfaction, and quality of life—outcomes that ultimately define the success of any clinical framework.

Current Urology
SUNY Upstate Medical University (US)
Openalex Percentile: Top 35%
Urinary Bladder and Prostate Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.